Contrary, no impact of GLP-1 receptor analogue monotherapy on nuclear androgen receptor was observed [69]
15: Sikiric P, Sever M, Krezic I, Vranes H, Kalogjera L, Smoday IM, Vukovic V, Oroz K, Coric L, Skoro M, Kavelj I, Zubcic S, Sikiric S, Beketic Oreskovic L, Oreskovic I, Blagaic V, Brcic K, Strbe S, Staresinic M, Boban Blagaic A, Skrtic A, Seiwerth S
Establish an appropriate selection concentration using a kill curve assay before formal selection to avoid excessive cell death
Novo Nordisk: Patenting Activity Novo Nordisks patent filing activity surged in 2017, coinciding with the U.S
doi: 10.1186/1471-2202-13-33 89 IrwinM
This is most relevant for medications with narrow therapeutic windows, where small changes in absorption can affect how the drug works